| INTRODUCTION
Sudden cardiac death (SCD) remains a major health-related problem, with an annual incidence of 0.1%-0.2% in the general population. Despite enormous efforts, there is still a long way until In this article, we review the indications for primary prevention ICDimplantationinpatientswithcoronaryarterydisease(CAD)and dilatedcardiomyopathy(DCM).CurrentEuropean (Priori&Blomstrom-Lundqvist,2015) andNorthAmerican(Epsteinetal.,2013)guidelines arecriticallyevaluated,focusingontheneedforreappraisalofresultingclinicalpractices.Sincecost-efficacyisdirectlyproportionaltothe accurate identification of those that will benefit from it, we believe thatargumentspresentedheremayaddtocurrentunderstandingof the underlying pathophysiology and promote judicious health care policies.
| PATHOPHYSIOLOGY AND IMPLICATIONS FOR RISK STRATIFICATION ALGORITHMS
Approximately50%ofvictimsofcardiacarrestareindividualswith-out previously diagnosed heart disease, most of whom have occult coronaryatherosclerosis,withVT/VFpresentingasacomplicationof acutecoronarysyndromes; (Kolettis,2014) In CAD and DCM patients the incidence of VT/VF depends on theextentofmorphologicalchangesintheremodeledLV;hence,the value of indices describing LV dimensions and function have been long advocated in the evaluation of such patients. Furthermore, the riskforSCDinpatientswithheartfailureappearshigherduringthe earlydiseasestages,whenthemajorityofSCDeventsareattributable to sustained ventricular tachyarrhythmias (Mozaffarian etal., 2007; Narayananetal.,2013) .WithincreasingheartfailureseveritytherelativeproportionofdeathsduetoSCDdecreaseswithbothpredominantnonsuddenmodesandfrequentlybradyarrhythmicSCD.
TheincidenceofSCDamongpatientswithCADorDCMhasbeen extensively studied (Costantini etal., 2009; De Ferrari etal., 2007; Farrell etal., 1991; Hohnloser etal., 2004; Moss etal., 1996 Moss etal., , 2002 Schmittetal.,2001; Steinbecketal.,2009; Zamanetal.,2014) .ICDs promptlyterminatearrhythmicepisodesanddecreasetotalmortality in populations with high incidence of arrhythmic events and significantLVdysfunction, (Mossetal.,1996 (Mossetal., ,2002 (Epsteinetal.,2013; Priori&Blomstrom-Lundqvist,2015) .However, evidenceprovidedhereinmaybeviewedasstrengtheningtherapidly growingdemandforcriticalreappraisalofcurrentguidelines.
| LIMITATIONS OF EF AND CURRENT GUIDELINES FOR ICD SELECTION
EFissimpletoassessandhasbeenthebasicqualifyingcriterionof allprimarypreventiontrials.However,compellingevidenceindicates thattheuseofEFasstandaloneriskstratifierhaslimitedsensitivity andspecificityandisassociatedwithmajorlimitations.
1.
Firstly, EF dependence on loading conditions and heart rate limits its accuracy, EF measurement reproducibility in clinical practiceislowandsignificantalterationscanbeobservedduring the disease course, due to progressive remodeling, orsecondary to treatment.
2.
Secondly, EF is a powerful predictor for total mortality, being, in fact,morerobustlyrelatedtototalcardiacmortalitythantoSCD (Buxtonetal.,2007; Mäkikallioetal.,2005) . (Kolettis,2013) .
Thirdly,population-basedanalysisofcardiacarresthaveshownthat
The decreased incidence of ventricular tachyarrhythmias in the PCI-era has been demonstrated (Piers etal., 2011) . The Israeli ICD registry (Sabbag etal., 2015) Limitations of currently recommended guides are further exemplified by their low rate of adoption among clinicians across many countries.Morespecifically,intheU.S.,thepenetrationofguidelines appears to be less than 20%-25% (Narayanan etal., 2013 
| THE MULTIFACTORIAL APPROACH

| Competing mortality-comorbidities
Current European and North American guidelines stress that patientsneedtohaveareasonablesurvivalexpectancyoflongerthan 1yearinordertobenefitfromICDtherapy.Competingmortalitymay counterbalance the benefits derived from the ICD therapy (Epstein etal., 2013; Priori & Blomstrom-Lundqvist, 2015) . Indeed, sudden death may be due to a nontachyarrhythmic cause, such as electromechanical dissociation or a vascular event. Thus, the incidence of SCDamongICD-treatedpatientswithheartfailureisnotinsignificant (Connollyetal.,2000) .Itislikelythatsuchanincreasedincidenceof a nonamenable to ICD treatment sudden death may be more pro- 
| Arrhythmic mortality estimates
The need for establishing effective algorithms for arrhythmic risk stratification, incorporating several variables, became readily apparentduringtheearlyyearsofclinicalexperiencewiththeuseofICDs.
Retrospective analysis of MADIT II-patients with poor EF indicated variablebenefitofICDimplantation,dependingonage,NYHAfunctional class, renal function, QRS duration and the presence of atrial fibrillation (Goldenberg etal., 2008) . Correspondingly, ICD implantation was not beneficial in low-risk patients that actually had only few eventsduringfollow-up. Similarly, lowSCD risk was noted ina group of heart failure patients with EF<30%, in the absence of diabetesmellitus,LVdilatation(>60mm),highBNPvalues(>200pg/ml) orcomplexventricularectopy (Watanabeetal.,2006) .Ofnote,ICD implantationappearsalsonotbeneficialinveryhigh-riskpatients,facinghighmortalityratessecondarytoprogressivepumpfailure (Cheng etal.,2014; Mozaffarianetal.,2007; Sennietal.,2013) . QRS complexes, baroreflex sensitivity or inverse spatial QRS-T angle (Goldberger etal., 2014; Huikuri etal., 2009) . Lastly, indices of autonomic function, such as reduced heart rate variability (Arsenos etal., 2012; Huikuri etal., 2009) 
| Risk stratification in DCM
Thevalueofmostnoninvasiveriskstratifiershasbeenplacedindoubtin DCMpatients,withtheEFrecommendedasthesoleriskstratification method (Grimm,Christ,Bach,Muller,&Maisch,2003) .ThisapproachcontradictstheresultsofthreerandomizedtrialsofDCMthatfailedtoconfirm asurvivalbenefitafterEF-guidedICDimplantation, (Bänschetal.,2002; Kadishetal.,2004; Strickbergeretal.,2003) 
| Risk stratification in patients with EF≥35%
Afundamentalmisconceptionregardinglandmarktrials'resultsliesin the belief that they acquit asymptomatic patients with an EF≥35% fromSCDrisk.However,thesestudieswerenotdesignedinorderto assesswhichsubgroupwasathigherriskforSCDbut,rather,tode- VTorVFatPVS (Hilfiker,Schoenenberger,Erne,&Kobza,2015) .
Two additional studies (Exner etal., 2007; Ikeda etal., 2006) have identified a high-risk post-MI patient-subgroup with relatively well preserved EF, based on the presence of noninvasive electrocardiographic indices, such asTWA, nonsustainedVT, LPs and HRT.
F I G U R E 1 Emergingnewsuddencardiacdeathriskstratificationparadigmbasedonnewerevidence,incorporatingcompetingmortality assessment,aswellasnoninvasiveandinvasivetests.NoninvasivetestsareperformedbeforePVStoassesslikelihoodforfunctionalcircuit formation.PVSispivotalindeterminingthepotentialforarrhythmiasustenanceandguidetreatment,especiallyinintermediate-andlow-risk patients."ObserveandFollow-up"involvesrepeatingtestsforNIRFannuallyandPVSevery3-5years.NIRF=noninvasiveECGriskfactors, includingpresenceoflatepotentials(≥2/3criteria),frequentprematureventricularcontractions(≥30/hr),nonsustainedVT(≥1/24hr),abnormal heartrateturbulence(onset≥0%andslope≤2.5ms),positiveTwavealternans(≥65μV),reduceddecelerationcapacity(≤4.5ms),decreased heartratevariability(SDNN<70ms),prolongedQT c interval(>460msinmalesand>480msinfemales) Thishigh-risksubgroupassociatedwithahigherincidenceofserious arrhythmiceventscomprisedthe17%-20%oftotalstudypopulation. 
| THE NEED FOR RISK-RESTRATIFICATION PRIOR TO DEVICE GENERATOR REPLACEMENT
TheneedforriskrestratificationinpatientsscheduledtoundergoICD replacementduetogeneratorexhaustionhasreceivedrelativelyless attention (Kawata etal., 2016; Merchant, Quest, Leon, & El-Chami, 2016 ).Evidently,therisksofarrhythmicornonarrhythmicdeathconstitutedynamicallychanging,time-dependentparameters.Ithasbeen shownthatincaseswithabsenceofappropriateinterventionduring thepriorgeneratorservicelifewhiletheEFhasbeenimprovedabove theICDimplantationthreshold,consequent5-yearmajorarrhythmia occurrence rate is around 11% (1.5%-2.5% annually) (Kawata etal., 2016 (Reitan etal., 2015) demonstrate that in most cases cardiac resynchronization therapywill suffice, taken into account its inherent antiarrhythmic effects. Hence, the decision to maintain the defibrillatorcomponentofaCRTsystemshouldbemadeinthepresenceofclearevidenceofbenefit. 
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